Literature DB >> 11549559

Cancer mortality among workers exposed to amphibole-free chrysotile asbestos.

E Yano1, Z M Wang, X R Wang, M Z Wang, Y J Lan.   

Abstract

The issue of whether exposure to chrysotile asbestos alone, without contamination from amphibole asbestos, causes lung cancer and mesothelioma was investigated in a 25-year longitudinal study (1972-1996) in Chongqin, China. The study cohort comprised 515 male asbestos plant workers exposed to chrysotile only; the control cohort included 650 non-dust-exposed workers. The results of analysis in which the proportional hazards model was used indicated that mortality due to all causes, all cancers, and lung cancer was related to asbestos exposure; the relative risks, adjusted for age and smoking, were 2.9, 4.3, and 6.6, respectively. Fiber concentrations in the raw material section and the textile section of the plant were 7.6 and 4.5 fibers/ml, respectively. Because of differences between the study and control plants, the authors also compared various sections of the asbestos plant that had different levels of dust exposure. The adjusted relative risk of lung cancer was 8.1 for workers exposed to high versus low levels of asbestos. Two cases of malignant mesothelioma, one pleural and the other peritoneal, were found in the asbestos cohort. These results suggest that heavy exposure to pure chrysotile asbestos alone, with negligible amphibole contamination, can cause lung cancer and malignant mesothelioma in exposed workers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549559     DOI: 10.1093/aje/154.6.538

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

1.  History of asbestos related disease.

Authors:  P W J Bartrip
Journal:  Postgrad Med J       Date:  2004-02       Impact factor: 2.401

2.  Evaluation of exposure to the airborne asbestos in an asbestos cement sheet manufacturing industry in Iran.

Authors:  Davood Panahi; Hossein Kakooei; Hossein Marioryad; Ramin Mehrdad; Mohammad Golhosseini
Journal:  Environ Monit Assess       Date:  2010-09-18       Impact factor: 2.513

3.  Size- and type-specific exposure assessment of an asbestos products factory in China.

Authors:  Midori N Courtice; D Wayne Berman; Eiji Yano; Norihiko Kohyama; Xiaorong Wang
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-08-05       Impact factor: 5.563

4.  Analysis of mortality in chrysotile asbestos miners in China.

Authors:  Lili Du; Xiaorong Wang; Mianzhen Wang; Yajia Lan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

Review 5.  Cellular and molecular parameters of mesothelioma.

Authors:  Maria E Ramos-Nino; Joseph R Testa; Deborah A Altomare; Harvey I Pass; Michele Carbone; Maurizio Bocchetta; Brooke T Mossman
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

6.  Asbestos mortality: a Canadian export.

Authors:  Amir Attaran; David R Boyd; Matthew B Stanbrook
Journal:  CMAJ       Date:  2008-10-21       Impact factor: 8.262

7.  Mortality in a Chinese chrysotile miner cohort.

Authors:  Xiaorong Wang; Sihao Lin; Eiji Yano; Hong Qiu; Igtanius T S Yu; Lapah Tse; Yajia Lan; Mianzhen Wang
Journal:  Int Arch Occup Environ Health       Date:  2011-07-28       Impact factor: 3.015

8.  Chrysotile effects on the expression of anti-oncogene P53 and P16 and oncogene C-jun and C-fos in Wistar rats' lung tissues.

Authors:  Yan Cui; Yuchan Wang; Jianjun Deng; Gongli Hu; Faqin Dong; Qingbi Zhang
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-13       Impact factor: 4.223

Review 9.  Health risk of chrysotile revisited.

Authors:  David Bernstein; Jacques Dunnigan; Thomas Hesterberg; Robert Brown; Juan Antonio Legaspi Velasco; Raúl Barrera; John Hoskins; Allen Gibbs
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

10.  Follow-up study of chrysotile textile workers: cohort mortality and exposure-response.

Authors:  Misty J Hein; Leslie T Stayner; Everett Lehman; John M Dement
Journal:  Occup Environ Med       Date:  2007-04-20       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.